BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsLowNeutral
Announced Tue, 12 May · 22:42 IST

Bliss GVS Pharma Limited has informed the Exchange about Grant of Options under Bliss GVS Pharma Limited Employee Stock Options Plan 2019

Corporate Actions View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹276.00
prior close
₹274.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-0.9+0.8-0.5+4.0+0.3+5.4+2.5+4.7+9.1+64.3+59.4+92.0
Up moveDown movePending
AI summary

Bliss GVS Pharma Limited has granted 1,80,000 stock options to eligible employees under its Employee Stock Options Plan 2019. The options have an exercise price of Rs. 43 per share, which represents an 84.20% discount to the NSE closing price on May 11, 2026. Each option converts into one equity share of Re. 1 face value. The options vest in four equal annual instalments of 25% each, starting 12 months from the grant date. Employees have 6 months from the date of vesting to exercise the options, and any shares allotted will be subject to a 6-month lock-in period.

Likely market impact

The ESOP grant is positive for employee retention and alignment of interests but will result in equity dilution of 1,80,000 shares. The deep 84.20% discount on exercise price may raise concerns about shareholder value erosion if all options are eventually exercised.